Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5% | AVESİS

Marmara Üniversitesi Akademik Veri Yönetim Sistemi

Is It Justifiable to Move the Grade-1 Ki67 Index Cut-Off from 3% to 5% for Pancreatic Neuroendocrine Tumors as Has Been Proposed? The Cases That Fall to 3-5% Category Have Clinicopathologic Characteristics Closer to Those > 5%

Atıf İçin Kopyala

Reid M., Balci S., BAĞCI ÇULÇİ P., Saka B., Pehlivanoglu B., ERBARUT SEVEN İ., ...Daha Fazla

109th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Los-Angeles, Şili, 29 Şubat - 05 Mart 2020, cilt.33, ss.1673

Yayın Türü: Bildiri / Özet Bildiri
Cilt numarası: 33
Basıldığı Şehir: Los-Angeles
Basıldığı Ülke: Şili
Sayfa Sayıları: ss.1673
Marmara Üniversitesi Adresli: Evet